Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Cochlear Limited ( (AU:COH) ) has shared an update.
Cochlear Limited announced the cessation of 517 service rights securities as the conditions for these securities were not met by the end of March 2025. This announcement may impact the company’s capital structure but does not appear to have immediate implications for its operational or market positioning.
More about Cochlear Limited
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company is known for its cochlear implants, bone conduction implants, and acoustic implants, focusing on improving the quality of life for individuals with hearing loss.
YTD Price Performance: -11.20%
Average Trading Volume: 70
Technical Sentiment Signal: Strong Buy
Current Market Cap: $10.01B
For a thorough assessment of COH stock, go to TipRanks’ Stock Analysis page.